RA CAPITAL MANAGEMENT, L.P. sold 18.8% of their position (737.99K shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $11.88M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/15/2026ACC: 0001231919-26-000355
Director10% Owner
Since Feb 2021
-737.99K
Net shares
Net seller
$11.88M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
737.99K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−530.61K
Price / share
$16.15
Trade value
$8.57M
% of position
13.5%
4/13/2026
3.94M→3.40M
Common Stock
Indirect
Shares
−153.74K
Price / share
$15.97
Trade value
$2.46M
% of position
4.5%
4/14/2026
3.40M→3.25M
Common Stock
Indirect
Shares
−53.64K
Price / share
$16.01
Trade value
$858.84K
% of position
1.6%
4/15/2026
3.25M→3.20M
Total
Net shares
−737.99K
Net value
-$11.88M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/13/2026 | S · Sale | −530.61K | $16.15 | $8.57M | 13.5% | 3.94M | 3.40M |
| Common Stock Indirect | 4/14/2026 | S · Sale | −153.74K | $15.97 | $2.46M | 4.5% | 3.40M | 3.25M |
| Common Stock Indirect | 4/15/2026 | S · Sale | −53.64K | $16.01 | $858.84K | 1.6% | 3.25M | 3.20M |
| Total | −737.99K | -$11.88M | ||||||
Derivative Transactions0
No derivative transactions reported